HCPCS Code P9031: Platelets, leukocytes reduced, each unit

Key takeaways

HCPCS code P9031 describes platelets, leukocytes reduced, each unit, an active Level II blood product code effective since 2001.

Bill P9031 per unit administered, so each platelet unit transfused gets its own line on the claim.

Pair P9031 with revenue code 0384 (platelets) on the UB-04 rather than the general 0380 or 0389 catch-all codes.

P9031 differs from P9032 (irradiated platelets), and billing the wrong one is the most common platelet coding error.

Practice management software like Pabau tracks units administered, HCPCS assignments, and UB-04 claim preparation.

HCPCS code P9031 is the Level II code for one unit of leukocyte-reduced platelets. Hospital outpatient departments and transfusion services bill it per unit transfused. It is also one of the most frequently miscoded blood product codes, usually over the descriptor or the revenue code paired with it.

This reference covers the code’s full descriptor, its Medicare coverage under OPPS, and revenue code pairing on the UB-04. It also sets out the documentation payers ask for and the adjacent P-series codes most often confused with P9031.

HCPCS code P9031: Definition and clinical description

P9031 reports one unit of leukocyte-reduced platelets administered to a patient. The full official descriptor is: Platelets, leukocytes reduced, each unit. It belongs to the P-series of HCPCS Level II.

That coding system is maintained by the Centers for Medicare and Medicaid Services (CMS) for supplies and services not covered by CPT.

P9031 falls under the blood products category of HCPCS Level II codes, which covers pathology and laboratory blood components. It has been an active code since 2001 with no termination date.

What “Platelets, leukocytes reduced, each unit” means clinically

Leukoreduction is the process of filtering white blood cells (leukocytes) out of a blood component before transfusion. Standard platelet products contain residual leukocytes from the donor.

Those leukocytes can trigger febrile non-hemolytic transfusion reactions, cytomegalovirus (CMV) transmission, and platelet refractoriness in sensitized patients.

Removing them reduces these risks. The AABB (formerly American Association of Blood Banks) names these patient groups among the indications for leukoreduction.

• Immunocompromised patients
• Patients receiving repeated transfusions
• CMV-seronegative patients
• Candidates for a solid organ or bone marrow transplant

For billing purposes, the key distinction is this: leukoreduction changes the code. A standard platelet unit uses a different HCPCS descriptor. P9031 applies specifically when leukoreduction has been performed and documented before transfusion.

• Standard platelets (not leukoreduced): billed under a separate HCPCS descriptor
• Leukoreduced platelets (P9031): leukocytes removed via filtration before or at bedside
• Irradiated platelets (P9032): treated with gamma or X-ray radiation to prevent graft-versus-host disease – a distinct code and clinical process
• Pheresis platelets (P9035): collected from a single donor by apheresis – again a separate descriptor

Leukoreduction and irradiation are two separate processes. A blood bank can perform either one on its own or both on the same unit, and each combination has its own HCPCS code.

HCPCS code P9031 billing guidelines

P9031 is billed per unit administered. Each platelet unit given to the patient during a transfusion episode requires a separate line item on the claim. If a patient receives three units of leukoreduced platelets, bill P9031 with a quantity of three (or three separate lines, depending on payer requirements).

Verify unit counts against the transfusion record before the claim goes out. Discrepancies between documented units and billed units are a leading cause of audits in blood product billing.

Care settings and appropriate use

P9031 is used mainly in hospital outpatient settings, where it is reimbursed under the Hospital Outpatient Prospective Payment System (OPPS). It can also appear on inpatient claims, but the reimbursement rules differ.

Under inpatient PPS, blood products are usually bundled into the DRG payment rather than reimbursed separately. Do not assume OPPS unit-based logic carries over to an inpatient claim.

Pairing with revenue codes on the UB-04

Hospital outpatient claims use the UB-04 institutional claim form, where P9031 has to carry a revenue code. Submitting a clean claim requires the HCPCS code and the revenue code to appear correctly on the same claim line. Blood products sit in the 038x revenue code series.

Revenue code 0384 is the specific code for platelet components, so pair P9031 with 0384 rather than the general 0380 or the 0389 catch-all. CMS and MAC guidance direct facilities to report the specific component code wherever one exists.

Verify the pairing against current CMS OPPS transmittals and your Medicare Administrative Contractor (MAC) guidelines. Payer-specific requirements still vary by jurisdiction.

P9031 Medicare coverage and reimbursement

P9031 is a Medicare payable code under OPPS. CMS reimburses leukoreduced platelet units as separately payable blood products in the hospital outpatient setting.

Payment amounts are updated annually in the OPPS final rule, so check the current rate on the CMS hospital outpatient payment page before billing. Rates from a prior year do not carry forward.

Software built for billing teams stays current with OPPS payment classifications. That cuts manual fee schedule lookups and surfaces payment variances before a claim is submitted.

Medicare coverage considerations

Medicare coverage for leukoreduced platelets is generally established through national and local coverage determinations. Coverage may be subject to Local Coverage Determinations (LCDs) issued by individual MACs. Some MACs require documented clinical justification for leukoreduction when it is not a facility-wide universal leukoreduction program.

Medicaid coverage for P9031 varies by state. Each state Medicaid program sets its own blood product reimbursement policy. Contact your state Medicaid agency or managed care organization for current coverage rules. Tracking remittance advice from each payer shows coverage patterns and denial trends over time.

Mapping P9031 to your chargemaster

The revenue code on a UB-04 line comes from the chargemaster entry behind the charge, not from the coder working the claim. If the P9031 charge code is mapped to a general 038x entry, every claim inherits that mapping until someone corrects the master file.

Audit the mapping for each blood product charge code at least once a year, and again after any MAC guidance update. Confirm that the HCPCS code, the revenue code, and the unit of measure agree on the chargemaster line. Do that before the first claim of the year goes out.

Documentation requirements for billing P9031

Payers require specific documentation to support a P9031 claim. Missing or incomplete records are the main driver of post-payment recoupment in blood product billing. The transfusion record has to be complete before the claim is generated, not reconstructed after a payer asks for it.

• Physician order: a signed order for platelet transfusion, including the indication for leukoreduction (or documentation that universal leukoreduction is facility policy)
• Transfusion record: the completed transfusion documentation showing the unit identifier, start and stop time, patient identity verification, and vital signs
• Unit identification: the donation identification number (DIN) or unit number traceable back to the blood supplier
• Patient consent: signed informed consent for transfusion (requirements vary by state and facility policy)
• Clinical indication: the diagnosis or clinical justification for transfusion, documented in the medical record and supported by the ICD-10-CM codes billed on the same claim
• Leukoreduction confirmation: documentation confirming the unit was leukoreduced (either pre-storage from the blood supplier, or at bedside via an approved filter)

A complete transfusion record protects the facility during an audit and supports the medical necessity of every unit billed. Each unit billed under P9031 needs its own documentation trail.

Related HCPCS blood product codes

The P-series contains several closely related platelet codes. Three processing steps decide which one applies: apheresis collection, leukoreduction, and irradiation.

According to the AAPC HCPCS code reference, the adjacent codes most often confused with P9031 are P9032, P9035, and P9037. Their full descriptors and the rule for choosing between them are below.

The distinction between P9031 and P9032 matters most for billing accuracy. A unit can be leukoreduced but not irradiated, which is P9031, or irradiated but not leukoreduced, which is P9032.

A unit that has had both needs a code naming both processes. That is P9033 for a non-pheresis unit, or P9037 for a pheresis unit. Never substitute one code for another based on assumed processing.

The P-series sits inside a much larger Level II set, and our HCPCS code library covers the other families a transfusion service bills.

Common billing errors when coding leukoreduced platelets

Denied blood product claims are expensive for hospital transfusion services, and the same five errors recur across facilities. Each one has a fix that sits in the billing workflow rather than in the clinical record.

Upcoding P9031 to P9032

Billing P9032 when the unit was only leukoreduced is the most common error in this code set. P9032 may carry a higher payment rate in some payer contracts, because irradiation is an extra processing step. Billing it without documented irradiation is upcoding, whatever the intent. The transfusion record has to confirm the processing performed on every unit billed.

Failing to bill per unit

P9031 is billed per unit. A claim that bills a single line for P9031 regardless of how many units were transfused will be underpaid. Conversely, billing more units than the transfusion record documents is overbilling. The unit count on the claim must match the transfusion record exactly.

Missing revenue code pairing

Hospital outpatient claims for blood products require both the HCPCS code and the revenue code. Submitting P9031 without a 038x revenue code on the UB-04 triggers a claim rejection. Pairing it with 0380 or 0389 when 0384 applies can draw a rejection too, from any MAC that enforces specific component coding.

Inadequate leukoreduction documentation

Billing P9031 requires evidence that leukoreduction actually occurred. If the blood supplier delivered a standard platelet unit and bedside filtration was not performed, P9031 cannot be billed. The unit’s processing status must be traceable through the blood bank record. Facilities operating universal leukoreduction programs should record that policy in their billing procedures to support retrospective audits.

Duplicate billing across encounters

Blood products administered during a single transfusion episode should appear on one claim. Billing the same unit across multiple claims or dates of service without clinical justification triggers duplicate claim edits. Confirm that each unit identifier appears only once across the billing cycle for that patient.

How claims management software keeps P9031 lines clean

In most transfusion services the units are tracked in the blood bank system and the claim is built somewhere else. The unit count gets rekeyed, and the revenue code comes off a chargemaster nobody has audited this year. The mismatch only surfaces when the remittance arrives.

Practice management software like Pabau keeps the billing detail attached to the record that produced it. Insurer details live on the patient record, and each administered unit carries its own line with the HCPCS code and the supporting documentation. The claim is then assembled from the transfusion record instead of a re-entry.

Pabau also checks a claim for missing detail before it is sent. A line without a revenue code or a unit identifier gets caught rather than rejected. US practices submit through Claim.MD without leaving the system, which keeps the billing ledger and the claim history in step. That leaves your team working the units that were genuinely miscoded rather than reconstructing why a claim came back.

Streamline blood product billing with Pabau

Pabau’s claims management tools help hospital revenue cycle teams track units administered, assign correct HCPCS codes, and submit cleaner UB-04 claims with fewer denials.

Book a demo

Conclusion

Accurate P9031 billing rests on three habits. Pick the code that matches the processing actually performed. Bill one line per unit, and pair each line with revenue code 0384. The transfusion record is what proves all three.

What keeps a facility out of recoupment is agreement between its systems. The chargemaster, the blood bank record, and the claim all have to describe the same unit the same way. Align those three and most of the audit exposure goes away.

Pabau gives revenue cycle teams claim tracking, HCPCS code management, and insurer detail held on the patient record. Book a demo to see how it fits your transfusion service’s billing process.

Continue your research

Need to understand how clean claims reduce blood product denials? What makes a clean claim walks through the key components payers check before processing an institutional claim.

Want a broader view of how revenue cycle management connects to blood product billing? Revenue cycle management explained covers the full financial workflow from patient registration through remittance.

Seeing repeated denials on HCPCS blood product claims? Denial management in healthcare outlines systematic approaches to tracking, appealing, and preventing claim denials.

Frequently asked questions